Dr Chooi Kheng Chiew

MRCP (UK), Fellowship in Endocrinology, MBChB (Glasgow)

Bahasa Malaysia, English, Mandarin, Cantonese


Book An Appointment Bookmark This Doctor


Clinic Schedule and Appointment List

  • Mon 19/10
    Not Available
  • Tue 20/10
    Not Available
  • Wed 21/10
    Not Available
  • Thu 22/10
    Not Available
  • Fri 23/10
  • Sat 24/10
    Not Available


Enquiry and Contact Details



The Doctor

Specialises in



Research and


  • 2020 Samsuddin S, Arumugam PA, Md Amin MS, Yahya A, Musa N, Lim LL, Paramasivam SS, Ratnasingam J, Ibrahim L, Chooi KC, Tan ATB, Tan PC, Omar SZ, Samingan N, Kamar AA, Anuar Zaini A, Jalaluddin MY, Vethakkan SR. (2020). Maternal lipids are associated with newborn adiposity independent of GDM status, obesity and insulin resistance: a prospective observational cohort study. BJOG;127(4):490–499. doi:10.1111/1471-0528.16031 (IF 5.193) (ISI-Indexed)
  • 2019 Kheng Chiew Chooi, Jeyakantha Ratnasingam, Sharmila Paramasivam, Luqman Ibrahim, Alexander Tan, Quan Lim, Mazlina Mazlan, Ronie Romelean Jayapalan, Sheau Fung Sia, Shireene Vethakkan, Early Prevalence of Neuroendocrine Dysfunction after Spontaneous Aneurysmal Subarachnoid Haemorrhage: Interim Findings from a Prospective Cohort Study, Journal of the Endocrine Society, Volume 3, Issue Supplement_1, April-May 2019, OR11–5, https://doi.org/10.1210/js.2019-OR11-5
  • 2019 Investigator for Clinical Trial – Efficacy and Safety of Finerenone in Subjects with Type 2 Diabetes Mellitus and Diabetic Kidney Disease (FIDELIO-DKD)
  • 2018 Investigator for Clinical Trial – A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes (PIONEER 6)
  • 2017 Real world efficacy and safety of empagliflozin in Malaysian type 2 diabetes mellitus patients, International Diabetes Federation Congress 2017, International Diabetes Federation.
  • 2017 Investigator for Study - Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT) (DKD-TMT)
  • 2016 ZERO END-DIGIT PREFERENCE IN BLOOD PRESSURE RECORDING IN A PRIMARY CARE SETTING IN MALAYSIA, The 26th Scientific Meeting of the International Society of Hypertension, International Society of Hypertension.
  • 2016 Jeyakantha Ratnasingam, Kheng Chiew Chooi, Syahrizan Samsuddin, Sharmila Paramasivam, Luqman Ibrahim, Lee Ling Lim,Alexander Tan, and Shireene Vethakkan (2016) VISUAL VIGNETTES-PERSISTENT HEADACHES WITH APPARENT EMPTY SELLA SYNDROME. Endocrine Practice In-Press. doi: http://dx.doi.org/10.4158/EP161568.VV (ISI-Indexed)
  • 2016 Principal Investigator for Clinical Trial - An Asian, phase 3, multicenter, randomized, double-blind, placebo-controlled 14-week study of DS-5565 in patients with diabetic peripheral neuropathic pain followed by a 52-week open-label extension
  • 2016 Principal Investigator for Clinical Trial NN 9535-4191- Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects with Type 2 Diabetes
  • 2016 Principal Investigator for Clinical Trial NN 304-4093- A 26-week open label, randomised, 2-armed, parallel group, multi-centre trial investigating efficacy and safety of insulin detemir versus insulin Neutral Protamine Hagedorn in combination with metformin and diet/exercise on glycaemic control in children and adolescents with type 2 diabetes insufficiently controlled on metformin ± other oral antidiabetic drug(s) ± basal insulin
  • 2015 Principal Investigator for Global Anticoagulant Registry in the FIELD observing treatment and outcomes in patients with treated acute Venous Thromboembolic Events in the real world
  • 2015 Investigator for Clinical Trial-A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy
  • 2014 Investigator for VISION Study- Verifying Insulin Strategy and Initial Health Outcome Analysis
  • 2014 Principal Investigator for QUALIFY Study- QUAlity of adherence to guideline recommendations for LIfe-saving treatment in heart failure: an international survey
  • 2014 Principal investigator for Clinical Trial NN9924-3790- Multiple dose trial examining dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetes
  • 2014 Investigator for Clinical Trial- A multicenter, international, randomized, parallel group, double-blind, placebo-controlled Cardiovascular Safety & Renal Microvascular outcome study with Linagliptin, 5 mg once daily in patients with type 2 diabetes mellitus at high vascular risk
  • 2014 Perceptions of Type 2 Diabetes Mellitus Patients towards Insulin Therapy in a District Specialist Hospital
  • 2013 Investigator for Clinical Trial- A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus
  • 2013 Sub-investigator for HAT Study (INS-4019)- An International Survey on Hypoglycaemia among Insulin-treated Patients with Diabetes


Fellowships, Memberships &

Professional Affiliations

  • Fellowship in Endocrinology (Malaysia)
  • Membership of the Royal College of Physicians (United Kingdom)
  • Certified Medical Impairment Assessor (CMIA)
  • Endocrine Society (USA)
  • Master of Health Research Ethics Programme Coordinator (Johns Hopkins University collaboration)
  • Malaysian Endocrine and Metabolic Society
  • Malaysian Osteoporosis Society
  • Malaysian Society of Hypertension


Awards and


  • Excellent Service Award (Ministry of Health, Malaysia)
  • Trades House Medical Prize (For the highest marks attained in the written and clinical final examinations) (University of Glasgow)
  • Duke Elder Undergraduate Prize in Ophthalmology (The Royal College of Ophthalmologists, United Kingdom)
  • Dr Saidi Hashim Memorial Gold Medal (IMU)